Evidence map›Paper›PMID 36213996›Full record

ArticleJournal of Alzheimer's disease : JAD2022

Cancer and Vascular Comorbidity Effects on Dementia Risk and Neuropathology in the Oldest-Old.

Christian Lachner, Gregory S Day, Gamze Balci Camsari, Naomi Kouri, Nilüfer Ertekin-Taner, Bradley F Boeve, Sydney A Labuzan, John A Lucas, E Aubrey Thompson, Habeeba Siddiqui and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 3 institutions in 1 country.

Christian LachnerDepartments of Neurology, Mayo Clinic, Jacksonville, FL, USA.
Gregory S DayDepartments of Neurology, Mayo Clinic, Jacksonville, FL, USA.
Gamze Balci CamsariDepartments of Neurology, Mayo Clinic, Jacksonville, FL, USA.
Naomi KouriDepartments of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Nilüfer Ertekin-TanerDepartments of Neurology, Mayo Clinic, Jacksonville, FL, USA.
Bradley F BoeveDepartments of Neurology, Mayo Clinic, Rochester, MN, USA.
Sydney A LabuzanDepartments of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
John A LucasDepartments of Psychiatry and Psychology, Mayo Clinic, Jacksonville, FL, USA.
E Aubrey ThompsonDepartments of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA.
Habeeba SiddiquiDepartments of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL, USA.
Julia E CrookDepartments of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL, USA.
Janisse N Cabrera-RodriguezDepartments of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Keith A JosephsDepartments of Neurology, Mayo Clinic, Rochester, MN, USA.
Ronald C PetersenDepartments of Neurology, Mayo Clinic, Rochester, MN, USA.
Dennis W DicksonDepartments of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
R Ross ReichardDepartments of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Michelle M MielkeDepartments of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
David S KnopmanDepartments of Neurology, Mayo Clinic, Rochester, MN, USA.
Neill R Graff-RadfordDepartments of Neurology, Mayo Clinic, Jacksonville, FL, USA.
Melissa E MurrayDepartments of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Mayo Clinic in Florida · USMayo Clinic · USMayo Clinic in Arizona · US

Funding

Vascular Structure and Function in Cognitive AgingP01AG003949 · NIA · YESHIVA UNIVERSITY · PI Richard B. LIPTON · 1985 to 2026
$73.9M
Early Onset AD Consortium - the LEAD Study (LEADS)U01AG057195 · NIA · INDIANA UNIVERSITY INDIANAPOLIS · PI APOSTOLOVA, LIANA G, CARRILLO, MARIA C · 2018 to 2023
$70.3M
SUPPLEMENT TO ALZHEIMERS DISEASE PATIENT REGISTRYU01AG006786 · NIA · MAYO CLINIC ROCHESTER · PI GRAFF-RADFORD, JONATHAN, JACK, CLIFFORD R. · 1986 to 2023
$49.6M
Project 4 (Genetic modifiers for APOE-associated Alzheimer's disease pathogenesis)U19AG069701 · NIA · MAYO CLINIC JACKSONVILLE · PI DAVID M. HOLTZMAN · 2021 to 2026
$42.0M
Research Education ComponentP30AG062677 · NIA · MAYO CLINIC ROCHESTER · PI KEJAL KANTARCI · 2019 to 2026
$33.5M
Integrating the exposome and methylome to inform brain molecular changes in ADRD across established diverse cohorts.U01AG046139 · NIA · UNIVERSITY OF FLORIDA · PI ERTEKIN-TANER, NILUFER, FUNK, CORY · 2013 to 2022
$24.6M
Investigating regional and cellular vulnerabilities to tau pathology in young-onset Alzheimer's diseaseR01AG075802 · NIA · MAYO CLINIC JACKSONVILLE · PI BERNARDINO Francesco GHETTI, Lea Tenenholz Grinberg · 2022 to 2026
$15.5M
Rochester Epidemiology ProjectR01AG034676 · NIA · MAYO CLINIC ROCHESTER · PI ROCCA, WALTER A, ST SAUVER, JENNIFER LYNN · 2010 to 2019
$9.5M
Neuropathology CoreP50NS072187 · NINDS · MAYO CLINIC JACKSONVILLE · PI DICKSON, DENNIS WILLIAM · 2010 to 2017
$8.7M
Clinical Features and Neuropathological Basis of Sleep Wake Behavior in Alzheimer's and PSPR01AG060477 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Lea Tenenholz Grinberg, Thomas C Neylan · 2019 to 2026
$8.2M
Understanding the role of TDP-43 in Alzheimers disease and FTLDR01AG037491 · NIA · MAYO CLINIC ROCHESTER · PI JOSEPHS, KEITH A · 2010 to 2024
$6.5M
MarkVCID Validation in the General CommunityUF1NS125417 · NINDS · MAYO CLINIC ROCHESTER · PI PETERSEN, RONALD C, VEMURI, PRASHANTHI · 2021 to 2023
$6.1M
NIA NIH HHS K23 AG064029NIA NIH HHS P01 AG003949NIA NIH HHS P30 AG062677NIA NIH HHS R01 AG034676NIA NIH HHS R01 AG037491NIA NIH HHS R01 AG054449NIA NIH HHS R01 AG060477NIA NIH HHS R01 AG061796NIA NIH HHS R01 AG062622NIA NIH HHS R01 AG075802NIA NIH HHS RF1 AG069052NIA NIH HHS U01 AG006786NIA NIH HHS U01 AG046139NIA NIH HHS U01 AG057195NIA NIH HHS U19 AG069701NIDCD NIH HHS R01 DC014942NINDS NIH HHS P50 NS072187NINDS NIH HHS R01 NS089757NINDS NIH HHS UF1 NS125417
6 · The paper itself

Abstract

backgroundDementia, vascular disease, and cancer increase with age, enabling complex comorbid interactions. Understanding vascular and cancer contributions to dementia risk and neuropathology in oldest-old may improve risk modification and outcomes.

objectiveInvestigate the contributions of vascular factors and cancer to dementia and neuropathology.

methodsLongitudinal clinicopathologic study of prospectively followed Mayo Clinic participants dying≥95 years-old who underwent autopsy. Participants were stratified by dementia status and compared according to demographics, vascular risk factors, cancer, and neuropathology.

resultsParticipants (n = 161; 83% female; 99% non-Hispanic whites)≥95 years (95-106 years-old) with/without dementia did not differ based on demographics. APOE ɛ2 frequency was higher in no dementia (20/72 [28%]) versus dementia (11/88 [12%]; p = 0.03), but APOE ɛ4 frequency did not differ. Coronary artery disease was more frequent in no dementia (31/72 [43%]) versus dementia (23/89 [26%]; p = 0.03) associated with 56% lower dementia odds (odds ratio [OR] = 0.44 [confidence interval (CI) = 0.19-0.98]; p = 0.04) and fewer neuritic/diffuse plaques. Diabetes had an 8-fold increase in dementia odds (OR = 8.42 [CI = 1.39-163]; p = 0.02). Diabetes associated with higher cerebrovascular disease (Dickson score; p = 0.05). Cancer associated with 63% lower dementia odds (OR = 0.37 [CI = 0.17-0.78]; p < 0.01) and lower Braak stage (p = 0.01).

conclusionCancer exposure in the oldest-old was associated with lower odds of dementia and tangle pathology, whereas history of coronary artery disease was associated with lower odds of dementia and amyloid-β plaque pathology. History of diabetes mellitus was associated with increased odds of dementia and cerebrovascular disease pathology. Cancer-related mechanisms and vascular risk factor reduction strategies may alter dementia risk and neuropathology in oldest-old.

Indexed as

Alzheimer DiseaseCerebrovascular DisordersCoronary Artery DiseaseDiabetes MellitusNeoplasmsNervous System DiseasesAged, 80 and overApolipoproteins EComorbidityFemaleHumansMaleNeuropathologyPlaque, AmyloidApolipoproteins EAgingAlzheimer’s diseasecancerdementianeuropathologyvascular disease

Identifiers

PMID36213996
PMCPMC9661335
OpenAlexW4300981029

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.